LIXTE BIOTECHNOLOGY HLDGS IN LIXT
COM · Common Stock · CUSIP 539319202
9
institutional holders
+5 vs Q4 2020
1.3m
shares reported held*
$4.4mreported value*
7 new
0 added
0 reduced
2 sold out
net bought ≈ $3.6m (+1.1m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.29.
Trends to Q1 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2020 | 4 |
| Q1 2021 | 9 |
Biggest buyers
| Almanack Investment Partners, LLC. | New | +1.0m |
| SABBY MANAGEMENT, LLC | New | +79.7k |
| CITADEL ADVISORS LLC | New | +23.8k |
| MORGAN STANLEY | New | +21.1k |
| Tower Research Capital LLC (TRC) | New | +1.6k |
| BlackRock Inc. | New | +303 |
| WELLS FARGO & COMPANY/MN | New | +16 |
Biggest sellers
| Anson Funds Management LP | Sold out | -57.1k |
| UBS Group AG | Sold out | -1.7k |
Holders, Q1 2021
| Manager | Shares | Change |
|---|---|---|
| Almanack Investment Partners, LLC. 0.35% of their portfolio | 1.0m $3.4m | New |
| SANTA MONICA PARTNERS LP 0.35% of their portfolio | 166.7k $548.0k | Unchanged |
| SABBY MANAGEMENT, LLC 0.19% of their portfolio | 79.7k $262.0k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 23.8k $79.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 21.1k $69.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.6k $5.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 303 $1.0k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 16 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |